United Therapeutics (UTHR) stock rises as the company eliminates Pfizer (PFE) royalties linked to lung disease drug ralinepag for $525M. Read more here.
(AP) — United Therapeutics Corp. (UTHR) on Wednesday reported third-quarter profit of $258.
United Therapeutics (NasdaqGS:UTHR) received FDA clearance to begin clinical trials of Treprostinil-Iloprost SMI for pulmonary arterial hypertension. The investigational therapy pairs two prostacyclin analogues and is designed as an as-needed treatment rather than continuous dosing. The business reported new designated pathogen-free xenotransplantation facilities in Houston and Stewartville to support commercial-scale xeno-organ production. Treprostinil-Iloprost SMI trial clearance and the...
This is the newest page. Registered accounts read further back.